| 000 | 01610 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514162222.0 | ||
| 264 | 0 | _c20040219 | |
| 008 | 200402s 0 0 eng d | ||
| 022 | _a1398-2273 | ||
| 024 | 7 |
_a10.1034/j.1399-3062.2003.00027.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBusca, A | |
| 245 | 0 | 0 |
_aInfectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation. _h[electronic resource] |
| 260 |
_bTransplant infectious disease : an official journal of the Transplantation Society _cSep 2003 |
||
| 300 |
_a132-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBacterial Infections _xepidemiology |
| 650 | 0 | 4 |
_aCytomegalovirus _xisolation & purification |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xprevention & control |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycoses _xepidemiology |
| 650 | 0 | 4 | _aMyeloablative Agonists |
| 650 | 0 | 4 | _aTransplantation Conditioning |
| 700 | 1 | _aLocatelli, F | |
| 700 | 1 | _aBarbui, A | |
| 700 | 1 | _aGhisetti, V | |
| 700 | 1 | _aCirillo, D | |
| 700 | 1 | _aSerra, R | |
| 700 | 1 | _aAudisio, E | |
| 700 | 1 | _aFalda, M | |
| 773 | 0 |
_tTransplant infectious disease : an official journal of the Transplantation Society _gvol. 5 _gno. 3 _gp. 132-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1034/j.1399-3062.2003.00027.x _zAvailable from publisher's website |
| 999 |
_c14354265 _d14354265 |
||